BackgroundCheck.run
Search For

Alastair James King, 56Saint Peters, MO

Alastair King Phones & Addresses

Lake Saint Louis, MO   

433 Mill Grove Dr, Norristown, PA 19403    610-6660118   

805 Mill Grove Dr, Norristown, PA 19403    610-6660118   

Eagleville, PA   

5134 Mccarty St, Indianapolis, IN 46254    317-3471175   

Bloomington, IN   

Lake Saint Louis, MO   

433 Mill Grove Dr, Norristown, PA 19403   

Work

Position: Sales Occupations

Mentions for Alastair James King

Publications & IP owners

Wikipedia

Alastair King Photo 24

Alastair King

Alastair King (born 1967) is a British composer, perhaps best known for his music for film and television. He studied music at Bath College of Higher Education, ...

Us Patents

Method To Determine Inhibition Of Pak3 Activation Of Raf-1

US Patent:
6383734, May 7, 2002
Filed:
Sep 30, 1998
Appl. No.:
09/163507
Inventors:
Mark Steven Marshall - Carmel IN
Henry Bruce Diaz - Indianapolis IN
Alastair James King - Indianapolis IN
Huaiyu Sun - Indianapolis IN
Assignee:
Advanced Research and Technology Institute, Inc. - Indianapolis IN
International Classification:
C12Q 100
US Classification:
435 4, 435 71, 435 771, 435 723
Abstract:
A method is provided to determine the ability of a test compound to alter PAK activation of Raf-1 comprising: (a) contacting a polypeptide comprising the catalytic domain of a PAK with the test compound in the presence of Raf-1; and (b) measuring the extent of activation of Raf-1.

Egfr And C-Met Fibronectin Type Iii Domain Binding Molecules

US Patent:
2021020, Jul 8, 2021
Filed:
Feb 12, 2021
Appl. No.:
17/174524
Inventors:
- Horsham PA, US
Ricardo Attar - Lawrence Township NJ, US
Michael Diem - Havertown PA, US
Linus Hyun - King of Prussia PA, US
Steven Jacobs - North Wales PA, US
Alastair King - Lake Saint Louis MO, US
Donna Klein - Philadelphia PA, US
Sheri Moores - Wayne PA, US
Karyn O'Neil - Media PA, US
Kristen Picha - Malvern PA, US
International Classification:
C07K 14/705
C07K 14/78
C07K 14/71
C07K 16/28
C07K 14/47
Abstract:
Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.

Cysteine Engineered Fibronectin Type Iii Domain Binding Molecules

US Patent:
2020032, Oct 15, 2020
Filed:
Apr 6, 2020
Appl. No.:
16/840479
Inventors:
- Horsham PA, US
Ricardo Attar - Lawrence Township PA, US
Michael Diem - Havertown PA, US
Shalom Goldberg - Merion Station PA, US
Linus Hyun - King of Prussia PA, US
Steven Jacobs - North Wales PA, US
Alastair King - Lake Saint Louis MO, US
Donna Klein - Philadelphia PA, US
Sheri Moores - Wayne PA, US
Karyn O'Neil - Media PA, US
Kristen Picha - Malvern PA, US
International Classification:
C07K 14/78
C07K 14/71
C12N 15/64
C12N 15/09
C12N 15/63
C07K 19/00
Abstract:
Cysteine engineered monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules comprising one or more free cysteine amino acids are prepared by mutagenizing a nucleic acid sequence of a parent molecule and replacing one or more amino acid residues by cysteine to encode the cysteine engineered FN3 domain containing monospecific or bispecific molecules; expressing the cysteine engineered FN3 domain containing molecules; and recovering the cysteine engineered FN3 domain containing molecule. Isolated cysteine engineered monospecific or bispecific FN3 domain containing molecules may be covalently attached to a detection label or a drug moiety and used therapeutically.

Cysteine Engineered Fibronectin Type Iii Domain Binding Molecules

US Patent:
2017036, Dec 21, 2017
Filed:
Jun 21, 2017
Appl. No.:
15/629090
Inventors:
- Horsham PA, US
Ricardo Attar - Lawrence Township PA, US
Michael Diem - Havertown PA, US
Linus Hyun - King of Prussia PA, US
Alastair King - Lake Saint Louis MO, US
Steven Jacobs - North Wales PA, US
Shalom Goldberg - Merion Station PA, US
Donna Klein - Philadelphia PA, US
Sheri Moores - Wayne PA, US
Karyn O'Neil - Media PA, US
Kristen Picha - Malvern PA, US
International Classification:
C07K 14/78
Abstract:
Cysteine engineered monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules comprising one or more free cysteine amino acids are prepared by mutagenizing a nucleic acid sequence of a parent molecule and replacing one or more amino acid residues by cysteine to encode the cysteine engineered FN3 domain containing monospecific or bispecific molecules; expressing the cysteine engineered FN3 domain containing molecules; and recovering the cysteine engineered FN3 domain containing molecule. Isolated cysteine engineered monospecific or bispecific FN3 domain containing molecules may be covalently attached to a detection label or a drug moiety and used therapeutically.

Egfr And C-Met Fibronectin Type Iii Domain Binding Molecules

US Patent:
2017030, Oct 26, 2017
Filed:
Jun 29, 2017
Appl. No.:
15/637276
Inventors:
- Horsham PA, US
Ricardo Attar - Lawrence Township NJ, US
Michael Diem - Havertown PA, US
Linus Hyun - King of Prussia PA, US
Steven Jacobs - North Wales PA, US
Alastair King - Lake Saint Louis MO, US
Donna Klein - Philadelphia PA, US
Sheri Moores - Wayne PA, US
Karyn O'Neil - Media PA, US
Kristen Picha - Malvern PA, US
International Classification:
C07K 14/78
A61K 45/06
C07K 14/47
C07K 14/71
C07K 16/28
C07K 16/28
C07K 14/705
A61K 39/00
A61K 38/00
Abstract:
Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.

Egfr And C-Met Fibronectin Type Iii Domain Binding Molecules

US Patent:
2014015, Jun 5, 2014
Filed:
Nov 20, 2013
Appl. No.:
14/085340
Inventors:
- Horsham PA, US
Ricardo Attar - Spring House PA, US
Michael Diem - Spring House PA, US
Linus Hyun - Spring House PA, US
Steven Jacobs - Spring House PA, US
Alastair King - Norristown PA, US
Donna Klein - Spring House PA, US
Sheri Moores - Spring House PA, US
Karyn O'Neil - Spring House PA, US
Kristen Picha - Spring House PA, US
Assignee:
Janssen Biotech, Inc. - Horsham PA
International Classification:
C07K 14/78
A61K 45/06
A61K 38/39
US Classification:
514 95, 530395, 530362, 536 234, 4353201, 435 697, 435325, 435365, 435369, 435352, 435358, 435370, 435367, 435354, 4352542, 435348, 435419, 43525233, 43525234, 4352523, 514 96, 435 691
Abstract:
Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.

Egfr And C-Met Fibronectin Type Iii Domain Binding Molecules

US Patent:
2014015, Jun 5, 2014
Filed:
Nov 21, 2013
Appl. No.:
14/086250
Inventors:
- Horsham PA, US
Ricardo Attar - Spring House PA, US
Michael Diem - Spring House PA, US
Linus Hyun - Spring House PA, US
Steven Jacobs - Spring House PA, US
Alastair King - Norristown PA, US
Donna Klein - Spring House PA, US
Sheri Moores - Spring House PA, US
Karyn O'Neil - Spring House PA, US
Kristen Picha - Spring House PA, US
Assignee:
Janssen Biotech, Inc. - Horsham PA
International Classification:
C07K 14/78
A61K 45/06
A61K 38/39
US Classification:
514 95, 530395, 530362, 5303873, 536 234, 435 697, 435325, 435365, 435369, 435352, 435358, 435370, 435354, 435367, 4352542, 435348, 435419, 4352523, 43525233, 43525234, 514 96, 4353201, 435 691
Abstract:
Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.